WuXi's LabNetwork integrates with Reaxys chemistry database

By Melissa Fassbender contact

- Last updated on GMT

WuXi’s LabNetwork integrates with Reaxys chemistry database

Related tags: Wuxi apptec, Chemical compound

WuXi AppTec’s LabNetwork is collaborating with Reaxys in order to simplify customer’s purchasing decisions and expand exposure to the WuXi eCommerce platform.

WuXi AppTec previously adopted Elsevier's technology​ to extract and index more than 500m experimental details. At the time, the company told us the five-year agreement was the foundation for a long-term strategic and collaborative relationship. 

As the next step in the relationship, LabNetwork's four million commercially available discovery and research compounds are now available on Elsevier’s chemistry database, Reaxys.

The integration will provide Reaxys users with access to both LabNetwork product availability and price information. Additionally, it will allow users to compare the cost of buying a compound versus making it internally.

This deepens integration of LabNetwork, WuXi’s eCommerce platform, with customers’ research and discovery workflows and expands key customers’ exposure to the WuXi eCommerce platform​,” the company told us in a statement.

Based on our goal of connecting global scientists and high-quality suppliers through a cost-effective trading platform for research supplies, we believe this integration with Reaxys is an exciting and meaningful development​.”

(Feature image: iStock/ipopba)

Related news

Related products

show more

Overcoming Challenges of Clinical Data Review

Overcoming Challenges of Clinical Data Review

PerkinElmer | 10-Jun-2021 | Technical / White Paper

Clinical data review is intrinsic to clinical development, assuring patient safety, determining drug efficacy, and assessing data quality. It involves...

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 09-Jun-2021 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-Jun-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Related suppliers

Follow us


View more